Chronic Lower Back pain Musculoskeletal Diseases Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. LBP for 12 weeks prior to enrollment 2. Pain upon deep palpation of the lumbar erector spinae 3. LBP from L1 to sacroiliac joint inclusive 4. Live within 50 miles of Rochester, NY 5. Have a baseline > 30mm on the Visual Analogue Scale (VAS) and > 20% on the Oswestry Disability Index (ODI) 6. Subjects had to be willing to undergo no new or different treatment during the study intervention and follow up period, although they were allowed to continue any medications.
Exclusion criteria
Exclusion criteria: 1. Radiographic or clinical evidence of cauda equina syndrome, spinal neoplasia or metastatic disease 2. Destructive joint pathology such as rheumatoid arthritis 3. Bowel/bladder dysfunction associated with the LBP 4. Peripheral neuropathy or progressive lumbosacral radiculopathy 5. Progressive myelopathy or neurogenic claudication 6. Spinal surgery within the past six months. 7. Subjects were excluded if they had undergone a course of SMT or supervised AET within the six months prior to enrollment into the study 8. If they could not perform an exercise program based on a New York Heart Association Classification of grade III or IV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Pain: Visual Analogue Scale 2. Disability: modified Oswestry Disability Index Outcome measures were administered at: baseline, immediately post intervention (4 weeks post baseline), 12 weeks post baseline and 24 weeks post baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Bodily Pain and Physical Functional subscales of the SF-36 2. Patient Satisfaction 3. Patient Expectation Outcome measures were administered at: baseline, immediately post intervention (4 weeks post baseline), 12 weeks post baseline and 24 weeks post baseline. | — |
Countries
United States of America